China pneumoconiosis and dust-exposure cohort
Official title: Pneumoconiosis and Dust Exposure China Cohort
Run by China-Japan Friendship Hospital · NCT07077382 · Data updated 2026-11-12
This project collects health, clinical, and work-history information from people in China with pneumoconiosis to describe disease course, prognosis, and complications.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | China-Japan Friendship Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | May 28, 2021 |
| Main results expected | March 31, 2026 |
| Study ends | May 31, 2030 |
| Registry record updated | July 22, 2025 |
| Trial ID | NCT07077382 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People diagnosed with pneumoconiosis in China who can provide a complete occupational history and have not participated in interventional clinical research.
✕Probably not a fit
People without a confirmed pneumoconiosis diagnosis, those unable to provide a full occupational history, or those who previously joined interventional trials may not benefit from this observational cohort.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort will enroll people in China diagnosed with occupational pneumoconiosis and gather demographic, occupational, and clinical data. Investigators will document disease stage, symptoms, comorbidities, and outcomes over time to describe the natural history and prognosis. Data will be collected at participating centers led by China-Japan Friendship Hospital and its regional collaborators using standardized clinical records and patient histories. Exclusion criteria include incomplete occupational history or prior participation in interventional research.
Why it matters
Potential benefit: If successful, the study could improve understanding of how pneumoconiosis progresses and which complications or comorbidities most affect patients, helping guide prevention and care.
How similar studies have gone: Similar observational cohorts of occupational lung disease have produced useful natural-history and risk-factor data, so the approach is established rather than novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed as pneumoconiosis Exclusion Criteria: * Incomplete occupational history information * Has participated in any interventional clinical research
Where it's running
-
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pirfenidone capsules to treat pneumoconiosis.
This 52-week test will see if pirfenidone capsules help adults aged 18–70 with pneumoconiosis compared with placebo.
-
BIS range and propofol depth during total IV anesthesia with adjuvants for knee replacement
This study tests the right BIS range and propofol level to keep anesthesia deep enough when using propofol with midazolam, dexmedetomidine, or esketamine in knee replacement patients.
-
Bariatric Surgery Combined With GLP-1RA in Obesity Patients
This study tests whether adding a GLP-1 receptor agonist after bariatric surgery helps people with obesity lose more weight and improve metabolism.
-
Multi-patient CT-derived Digital Twin Training to Shorten the Bronchoscopy Learning Curve
This trial tests if training with digital twins from multiple CT scans helps novices learn bronchoscopy faster than standard anatomically uniform simulation training.
-
How different drugs affect BIS-EEG during anesthesia with propofol-remifentanil
This study tests how adding drugs like midazolam, dexmedetomidine, or esketamine changes BIS and raw EEG readings in adults having elective gallbladder surgery under standard anesthesia.
-
Effect of pHA130 Hemoadsorption with Hemodialysis in Kidney Failure
Aims to see if adding the pHA130 hemoadsorption cartridge to dialysis helps reduce protein-bound toxins in people with end-stage kidney failure on maintenance dialysis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.